SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039477
Filing Date
2023-05-15
Accepted
2023-05-15 11:46:28
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_inmedpharma.htm   iXBRL 10-Q 767307
2 CERTIFICATION f10q0323ex31-1_inmedpharma.htm EX-31.1 11251
3 CERTIFICATION f10q0323ex31-2_inmedpharma.htm EX-31.2 11423
4 CERTIFICATION f10q0323ex32-1_inmedpharma.htm EX-32.1 3743
5 CERTIFICATION f10q0323ex32-2_inmedpharma.htm EX-32.2 3624
11 GRAPHIC image_001.jpg GRAPHIC 4153
  Complete submission text file 0001213900-23-039477.txt   4463980

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20230331.xsd EX-101.SCH 70742
7 XBRL CALCULATION FILE inm-20230331_cal.xml EX-101.CAL 31733
8 XBRL DEFINITION FILE inm-20230331_def.xml EX-101.DEF 232817
9 XBRL LABEL FILE inm-20230331_lab.xml EX-101.LAB 468633
10 XBRL PRESENTATION FILE inm-20230331_pre.xml EX-101.PRE 247170
70 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_inmedpharma_htm.xml XML 438096
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 23919907
SIC: 2834 Pharmaceutical Preparations